Gouin et al., 1982 - Google Patents
Treatment of bronchopulmonary infections with dibekacin.Gouin et al., 1982
- Document ID
- 10665450283693758228
- Author
- Gouin F
- Basse F
- Robert D
- Auboyer C
- Publication year
- Publication venue
- NOUV. PRESSE MED.
External Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0217580A3 (en) | Therapeutic nucleosides | |
GB8712073D0 (en) | Medicament | |
CA2044746A1 (en) | Polypeptide compound and a process for preparation thereof | |
HK1009101A1 (en) | Use of a composition comprising amoxycillin and clavulanic acid for the manufacture of a medicament for the treatment of bacterial infections in paediatric patients | |
Gouin et al. | Treatment of bronchopulmonary infections with dibekacin. | |
ES8707734A1 (en) | Cephalosporins, process for their preparation and their use in medicaments. | |
AU3733295A (en) | Treatment of obstructive airway disease by administering thymosin beta 4, or coadministration of thymosin beta 4 and dnase i | |
ES8607728A1 (en) | Drug combinations having synergistic effect | |
EP0286802A3 (en) | Use of ofloxacin in treating or preventing locally periodontal disease | |
RU93037431A (en) | ENTERSORBENT FOR THE REMOVAL OF RADIONUCLIDES DEPOSITED IN THE ORGANISM | |
EP0373388A3 (en) | Penem derivatives and process for their preparation | |
EP0337643A3 (en) | 6-substituted acrylamido penicillanic acid derivatives, preparation and use | |
IL82767A (en) | Synergistic formulation comprising a cephem and a penem derivative for the treatment of bacterial infections | |
GB2009154A (en) | Antibacterial compounds | |
ZA89811B (en) | B-lactam antibiotics,processes for their preparation and their use as and in medicaments | |
Sainty et al. | Treatment of hospital-acquired Pseudomonas aeruginosa lung infections with ceftazidime. Fifty cases from a respiratory intensive care unit. | |
Carbon | Effectiveness and safety of cefixime in international and French trials. | |
Herbrecht et al. | Piperacillin and netilmicin combination therapy of infections in granulocytopenic patients. | |
Otte et al. | Comparison of tetracycline and a combination of sulfamethopyrazin-trimethoprim in the treatment of acute sinusitis in adults. | |
IL60123A (en) | Pharmaceutical composition for the treatment of bactericidal infections of the urinary and genital tracts comprising lactobacillus acidophilus or doederlein's bacillus | |
ZA938915B (en) | Treatment of viral infections by conjunctive therapy with acyclovir-like compounds and a 2'-vynyl substituted nucleoside analog | |
Olay et al. | Experimental Staphylococcus aureus osteomyelitis treated with fosfomycin and cephazolin: Single and combined therapy. | |
MY102905A (en) | Therapeutic nucleosides | |
Tsukamura | Comparison of therapeutic effect on pulmonary tuberculosis among three different chemotherapy, EVM-RFP-INH, SM-RFP-INH and EB-RFP-INH. | |
Padovani et al. | Clinical efficacy and tolerance of ceftazidime as sole antibiotic in neonatal bacterial infections. |